Two Novel High-Risk Adult B Cell Acute Lymphoblastic Leukemia Subtypes with High Expression of CDX2 and IDH1/2 Mutations

Researchers advanced the understanding of biological characteristics, improved disease stratification, and identified molecular targets of adult B cell acute lymphoblastic leukemia (B-ALL). They highlighted the age-dependent distribution of subtypes in prognostic differences between adult and pediatric B-ALL.